Skip to content

ESD Home

TechCentury

Powered by

Engineering Society of Detroit Lawrence Technological University

Tag: Pharmaceuticals

Pharmaceuticals

Esperion loss grows as company begins selling cholesterol-fighting drugs

ANN ARBOR—Esperion Therapeutics Inc. reported a loss of $85.4 million or $3.07 a share in the third quarter of 2020, vs. a loss of $68.4 million or $2.52 a share …

Coronavirus / Nanotechnology / Pharmaceuticals

Ann Arbor pharma firm rolls out nasal disinfectant

ANN ARBOR—BlueWillow Biologics, a firm founded in 1999 that is developing nanotechnology for healthcare applications, announced the availability of NanoBio Protect on Amazon. NanoBio Protect is an alcohol-free antiseptic solution that …

Pharmaceuticals

Esperion’s new cholesterol-buster hits the market

ANN ARBOR—After years of development, Nexletol, the new cholesterol-reducer from Ann Arbor’s Esperion Therapeutics Inc., is now on the market and available in pharmacies in the United States. Nexletol uses …

Coronavirus / Economic Development / Medical Devices / Pharmaceuticals

Pure Michigan Business Connect offering virtual matchmaking for COVID-19 response gear

LANSING–The Michigan Economic Development Corp.’s Pure Michigan Business Connect program is now offering a free, online procurement platform to assist suppliers of critical health and human services across a broad …

Pharmaceuticals / Software

New pharma study safety software from Canton firm

CANTON TWP.—MMS Holdings Inc., a Canton Township-based contract research organization (CRO) for the pharmaceutical industry, announced the introduction of its Datacise Integrated Safety Explorer, which will debut at the Pharmaceutical …

Clinical Trials / Pharmaceuticals

Clinical trial evaluation firm changes name

ALLENDALE—QST Consultations Ltd. has announced that it has changed its name to Abond CRO Inc., launching the new brand through a new website and participation at participation at the Summit …

Pharmaceuticals / Startups

Millendo names chief commercial officer

ANN ARBOR—Millendo Therapeutics Inc. (Nasdaq: MLND), the developer of new endocrine drugs, announced the promotion of Thomas Hoover to the newly created position of chief commercial officer. Hoover joined Millendo …

Clinical Trials / Pharmaceuticals / Startups

GR Alzheimer’s drug developer changes name

GRAND RAPIDS—Tetra Discovery Partners, a clinical-stage biotechnology company, announced the company’s name change to Tetra Therapeutics. The name change reflects the company’s transition from a company focused on discovery research …

Clinical Trials / Pharmaceuticals / Seed Funding / Startups / Venture Capital

Pharma startup raises $5M to complete Phase 2 clinical trials

FARMINGTON HILLS—Ocuphire Pharma Inc., a clinical-stage pharmaceutical company developing therapies to treat patients with a variety of ophthalmic disorders, announced that it has closed on over $5 million of financing. …

Health Information Technology / Online Marketing / Pharmaceuticals

OptimizeRx raises $20 million in stock offering

(Updated June 5 with stock price) ROCHESTER—OptimizeRx Corp. (Nasdaq: OPRX), the Rochester-based provider of digital communication services for pharmaceutical companies to patients and healthcare providers, has announced a proposed underwritten …

Posts navigation

Older posts

Read the magazine:

TechCentury
Advertise or Contribute an Article
Lawrence Technological University

Subscribe to TechCentury.com

Top Posts

  • Michigan team takes fourth place at Future City nationals
  • Angel investor event to be held online April 20
  • OneStream Software gets $200M investment, $6B valuation
  • Michigan schools, nonprofits to get free internet to serve 4,100 at-risk students
  • First Shared Office Space In Grand Haven Opens For Tours

Archives

Follow Us On

© The Engineering Society of Detroit   |   ABOUT